These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33777698)

  • 1. TNNI3 and KCNQ1 co-inherited variants in a family with hypertrophic cardiomyopathy and long QT phenotypes: A case report.
    Cava F; Cristiano E; Musumeci MB; Savio C; Germani A; Monaco ML; Petrucci S; Torrisi MR; Autore C; Rubattu S; Piane M
    Mol Genet Metab Rep; 2021 Jun; 27():100743. PubMed ID: 33777698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease?
    Cava F; Micolonghi C; Musumeci MB; Petrucci S; Savio C; Fabiani M; Tini G; Germani A; Libi F; Rossi C; Visco V; Pizzuti A; Volpe M; Autore C; Rubattu S; Piane M
    Front Cardiovasc Med; 2023; 10():1112759. PubMed ID: 37089884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
    Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy.
    Gray B; Ingles J; Medi C; Semsarian C
    JACC Heart Fail; 2013 Apr; 1(2):149-55. PubMed ID: 24621839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.
    Johnson JN; Grifoni C; Bos JM; Saber-Ayad M; Ommen SR; Nistri S; Cecchi F; Olivotto I; Ackerman MJ
    Eur Heart J; 2011 May; 32(9):1114-20. PubMed ID: 21345853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between electrocardiographic and genetic mutation (MYH7-H1717Q, MYLK2-K324E and KCNQ1-R190W) phenotype in patients with hypertrophic cardiomyopathy].
    Shao H; Zhang Y; Liu L; Ma Z; Zuo L; Ye C; Wei X; Sun C; Tao L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):50-4. PubMed ID: 26813553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.
    Hurtado-de-Mendoza D; Corona-Villalobos CP; Pozios I; Gonzales J; Soleimanifard Y; Sivalokanathan S; Montoya-Cerrillo D; Vakrou S; Kamel I; Mormontoy-Laurel W; Dolores-Cerna K; Suarez J; Perez-Melo S; Bluemke DA; Abraham TP; Zimmerman SL; Abraham MR
    J Arrhythm; 2017 Jun; 33(3):201-207. PubMed ID: 28607615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children.
    Martin AB; Garson A; Perry JC
    Am Heart J; 1994 Jan; 127(1):64-70. PubMed ID: 8273757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of ion channel gene variants in patients with long QT syndrome.
    Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
    Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death.
    Boczek NJ; Ye D; Jin F; Tester DJ; Huseby A; Bos JM; Johnson AJ; Kanter R; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1122-32. PubMed ID: 26253506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
    Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT-interval abnormalities in hypertrophic cardiomyopathy.
    Dritsas A; Sbarouni E; Gilligan D; Nihoyannopoulos P; Oakley CM
    Clin Cardiol; 1992 Oct; 15(10):739-42. PubMed ID: 1395184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
    Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
    BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Orosz A; Baczkó I; Nagy V; Gavallér H; Csanády M; Forster T; Papp JG; Varró A; Lengyel C; Sepp R
    Can J Physiol Pharmacol; 2015 Sep; 93(9):765-72. PubMed ID: 26313025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
    Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease.
    Melas M; Beltsios ET; Adamou A; Koumarelas K; McBride KL
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
    Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
    PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.